Search

everythinglearnresearchcommunity

for

Search:↓

The study created a new method to test drugs that affect hormone processing in skin.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Excess androgens may cause PCOS, not just be a symptom.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Gene mutations can cause problems in male genital development.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Gene variation affects prostate issues and hair loss.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Iron deficiency might contribute to hair loss in women.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

PCOS is linked to metabolic issues and infertility, needing more research.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Two young siblings experienced hair loss without hormone issues or other skin problems.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Vitamin D levels do not significantly relate to the causes of PCOS or DOR in infertile patients.

Menopause affects hair and skin; more research needed for treatment.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.